{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "application/javascript": [
       "$.getScript('https://kmahelona.github.io/ipython_notebook_goodies/ipython_notebook_toc.js')"
      ],
      "text/plain": [
       "<IPython.core.display.Javascript object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "%%javascript\n",
    "$.getScript('https://kmahelona.github.io/ipython_notebook_goodies/ipython_notebook_toc.js')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "\n",
    "\n",
    "* [Lecture 1. Neurotransmitter receptors](#l1)\n",
    "    * [Part 1. Ionotropic receptors](#l1p1)\n",
    "    * [Part 2. Metabotropic receptors](#l1p2)\n",
    "    * [Part 3. Calcium as second messenger ](#l1p3)\n",
    "\n",
    "\n",
    "* [Lecture 2. GABA receptors](#l2)\n",
    "\n",
    "    * [Part 1. Ionotropic GABA-R](#l2p1)\n",
    "    * [Part 2. Metabotropic GABA-R](#l2p2)\n",
    "\n",
    "\n",
    "* [Lecture 3. Glutomate receptors](#l3)\n",
    "\n",
    "    * [Part 1. Ionotropic Glu-R ](#l3p1)\n",
    "    * [Part 2. NMDA-R](#l3p2)\n",
    "    * [Part 3. Metabotropic Glu-R](#l3p3)\n",
    "\n",
    "* [Lecture 4. Neurotransmitter Transporters](#l4)\n",
    "    * [Part 1. Introduction](#l4p1)\n",
    "    * [Part 2. NT (re)-uptake](#l4p2)\n",
    "    * [Part 3. NT release by “reversed uptake” ](#l4p3)\n",
    "    * [Part 4. Clinical relevance ](#l4p4)\n",
    "\n",
    "* [Lecture 5](#l5)\n",
    "    * [Part 1. How NT cause EPSP](#l5p1)\n",
    "    * [Part 2. Molecular mechanism](#l5p2)\n",
    "    * [Part 3. GABA and Glutamate receptors ](#l5p3)\n",
    "    * [Part 4. Electrical synapse](#l5p4)\n",
    "\n",
    "<!--* [Lecture 6](#l6)\n",
    "    * [Part 1. Introduction](#l6p1)\n",
    "    * [Part 2.  Long term synaptic plasticity](#l6p2)\n",
    "    * [Part 3. Sort term synaptic plasticity ](#l6p3)\n",
    "\n",
    "* [Lecture 7](#l7)\n",
    "    \n",
    "    * [Part 1. Unit recording ](#l7p1)\n",
    "    * [Part 2.  Multiunit recording](#l7p2)\n",
    "    * [Part 3. Local field potential](#l7p3)\n",
    "    * [Part 4. Microstimulation](#l7p4)\n",
    "    * [Part 5. Optogenetics](#l7p5)\n",
    "    * [Part 6. Calcium imaging](#l7p6)\n",
    "    * [Part 7. Voltage sensitive dyes imaging](#l7p4) -->"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id='l1'></a>\n",
    "### Lecture 1.  Neurotransmitter receptors\n",
    "\n",
    "There are three major classes of cell-surface receptors: \n",
    "- **Ion-channel-linked receptors**\n",
    "- **G-protein-linked receptors** \n",
    "- Enzyme-linked receptors (signal molecule activates enzyme)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id='l1p1'></a>\n",
    "#### Part 1. Ionotropic receptors\n",
    "\n",
    "- **Ionotropic** (NT opens an ion channel) - **fast, short-lasting** synaptic transmission\n",
    "Example: ionotropic nACh-receptor\n",
    ">\n",
    "> - **5 protein sub-units**, each from **4 regions**. \n",
    "> - **M2** regions create pore.\n",
    "> ![](images/l1g1.png)\n",
    "> **2 molecules of $ACh$** in $\\alpha_{\\gamma}$ and $\\alpha_{\\delta}$ sites\n",
    "> ![](images/l1g4.png)\n",
    "> - **3 rings** of *negatively* charged amino acids (Glu-, Asp-) \n",
    "> ![](images/l1g2.png)\n",
    "> \n",
    "> Binding of $ACh$ $\\rightarrow$ rotation (conformational change) $\\rightarrow$ opened state\n",
    "> ![](images/l1g3.png)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id='l1p2'></a>\n",
    "#### Part 2. Metabotropic receptors\n",
    "\n",
    "- **Metabotropic** NT receptor (NT triggers intracellular processes) - **slow, long-lasting**\n",
    "\n",
    "Classification (by binding)\n",
    ">  1. Binding site **inside the membrane** [Examples?]\n",
    ">  2. Binding site on the **surface of membrane** [Examples?]\n",
    ">  3. Binding site inside **long N-terminal** (venus flytrap module - **VFTM**)\n",
    "![](images/l1g5.png)\n",
    "\n",
    "Process: \n",
    "\n",
    ">Ligand binding $\\rightarrow$ Conformational change $\\rightarrow$ Binding & activation of G-protein\n",
    "\n",
    "Activation of G-protein: \n",
    "\n",
    ">Activated $\\alpha$ (with [GTP][1]) and $\\beta \\gamma$-subunits unbind from receptor $\\rightarrow$ $\\alpha$ (with GTP) binding to target protein and activate it $\\rightarrow$ $\\alpha$-subunit unbinds from target protein via energy from hydrolysis of GTP (GTP $\\rightarrow$ [GDP][2]) $\\rightarrow$ binding of $\\alpha$ and $\\beta \\gamma$-subunits $\\rightarrow$ inactivated G-protein. \n",
    "\n",
    "Amplification: \n",
    "\n",
    ">- G-protein $\\rightarrow$ $10^{10}$ [Glycogen molecules][3]\n",
    "- One Rodopsin molecule $\\rightarrow$ many $250 Na^+$ channels closed (rod cell hyperpolorized by $1 mV$)\n",
    "\n",
    "Activation of different processes(**coordinated modulation**): \n",
    "\n",
    ">- metabolic enzyme $\\rightarrow$ altered metabolism \n",
    "- gene regulatory protein $\\rightarrow$ altered gene expression\n",
    "- cytoskeletal protein $\\rightarrow$ altered cell shape and movement \n",
    ">\n",
    "Can be interaction between different processes triggered by second messengers (**crosstalk**)\n",
    "\n",
    "[1]:https://en.wikipedia.org/wiki/Guanosine_triphosphate\n",
    "[2]:https://en.wikipedia.org/wiki/Guanosine_diphosphate\n",
    "[3]:https://en.wikipedia.org/wiki/Glycogen"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id='l1p3'></a>\n",
    "#### Part 3. Calcium as second messenger \n",
    "\n",
    "Functions\n",
    ">In neurons \n",
    "- [neurotransmitter release][0] at the chemical synapse\n",
    "- gating of ion channels ( $Cl^-_{Ca}, K^+_{Ca}, Ca^{2+}_{Ca}$)\n",
    "- [gating of Ryanodin- and IP3-receptors][2] ($Ca^{2+}$-induced $Ca^{2+}$-release)\n",
    "- activation of various enzymes: $Ca^{2+}$-calmodulin, $Ca^{2+}$-protein kinases\n",
    "- activation of transcription factors – **gene expression**\n",
    "- involvement in ‘synaptic plasticity’ – [**LTP**][1]\n",
    "\n",
    "> In muscle cells\n",
    "- electromechanical coupling – $Ca^{2+}$-binding to troponin C (de-blockade of a-m-binding) ???\n",
    "- heart muscle cells: delayed $Ca^{2+}$-influx – prolongation of AP‘s\n",
    "\n",
    "Related problems\n",
    ">- increased $[Ca^{2+}]_{int}$ is neurotoxic ! (Glu NMDA-rec.)\n",
    "-  dysregulation of $Ca^{2+}$ can lead to various pathologies\n",
    "\n",
    "\n",
    "$Ca^{2+}$-compartments\n",
    "> $[Ca^{2+}]_{int}$ is very small and can change in 1000 times. So it have to be regulated precisely in space and time. \n",
    "\n",
    "> <img  src=\"images/l1g6.png\" width=400/>\n",
    "\n",
    "<a id='ryanodine'></a>\n",
    "Getting in \n",
    ">  - by voltage dependent channels \n",
    "      - L-type: high voltage, slow inactivation, inactivated by $Ca^{2+}$\n",
    "      - P/Q-types: high, slow, yes/no\n",
    "      - N-type: high, fast, yes\n",
    "      - R-type: high, fast, no\n",
    "      - T-type: **low **, very fast, no\n",
    "<a id='ip_3'></a>\n",
    ">   - by release from **intracellular stores** into the cytosol.(Ryanodine- und IP3-receptors) \n",
    "> <img  src=\"images/l1g7.png\" width=500/>\n",
    "\n",
    "Getting out\n",
    "> <img  src=\"images/l1g8.png\" width=500/>\n",
    "> $Ca^{2+}$-binding **proteins **: parvalbumine, calbindine (cytosol)\n",
    "calsequestrine (SER)\n",
    "\n",
    ">Mechanisms of $Ca^{2+}$-buffering\n",
    "- $Na^+-Ca^{2+}$-**transporter** in plasma membrane: **high capacity - low affinity** (to quickly remove $Ca^{2+}$ when the concentration is big)\n",
    "- $H^+-Ca^{2+}$- in mitochondria **transporter**: **high capacity - low affinity**\n",
    ">\n",
    ">- $Ca^{2+}$-ATPase **pump**: **low capacity - high affinity** (works even when there is small $[Ca^{2+}]$)\n",
    "  - PMCA: plasma membrane $Ca^{2+}$-pump\n",
    "  - SERCA: smooth endoplasmic reticulum $Ca^{2+}$-pump\n",
    "  - MMCA: mitochondrial membrane $Ca^{2+}$-pump\n",
    "\n",
    "[0]: ..\\neurophisiology\\neurophysiology.ipynb#l4p3\n",
    "[1]: ..\\neurophisiology\\neurophysiology.ipynb#l6p2\n",
    "[2]: #ryanodine"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id='l2'></a>\n",
    "### Lecture 2. GABA-receptors"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id='l2p1'></a>\n",
    "#### Part 1. Ionotropic GABA-receptors (GABA$_A$ and GABA$_C$)\n",
    "\n",
    "Properties\n",
    "\n",
    "> - GABA$_A$-R and GABA$_C$-R are anion channels\n",
    "> - they have conductance for $Cl^-$ (influx)\n",
    "> - M2 forms the pore – „selectivity filter“\n",
    "> - M2 has rings of positive charge (Lys+, Arg+)\n",
    "> - the $\\beta$-subunit binds GABA ($\\alpha$-subunit help a little)\n",
    "> - needed 2 GABA molecules\n",
    "> - GABA$_A$-R bind additional substances(**they modulate the channel properties**)\n",
    " \n",
    "Modulation of GABA$_A$-receptors (GABA$_C$ doesn't have such properties )\n",
    "> benzodiazepine binding (only with $\\gamma$-subunit and only $\\alpha_1$ has **high** affinity )\n",
    "> <img  src=\"images/l2g2.png\" width=300/>\n",
    "> Experiment: Potentiation of GABA$_A$-receptor currents \n",
    ">>1. transfection of Xenopus oocytes with cDNAs of $\\alpha$-, $\\beta$-, $\\gamma$-subunits\n",
    "2. recordings with whole-cell patch-clamp technique\n",
    "3. application of GABA alone\n",
    "4. co-application of GABA + benzodiazepines (diazepam - DZP, FNZM)\n",
    "5. co-application von GABA + barbiturates (pentobarbital - PB)\n",
    ">> <img  src=\"images/l2g3.png\" width=700/>\n",
    "> Result: benzodiazepines and  barbiturates induce **more inhibition**\n",
    "> The same result we can obtain by stimulation of GABA-ergic interneurons (pre-synapt.)\n",
    "in the **hippocampus** brain slice preparation\n",
    "> <img  src=\"images/l2g4.png\" width=400/>\n",
    "> So we see **potentiation of IPSP.**"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id='l2p2'></a>\n",
    "#### Part 2. Metabotrophic GABA-receptors (GABA$_B$ )\n",
    "\n",
    "Properties \n",
    "> - 2 types: GABA$_B$1a-d and GABA$_B$2a-c (only 35% sequence homology) \n",
    "  - B1 / B2 are “co-distributed” in the brain (are even expressed in the same cells)\n",
    "  - expressed in all brain areas \n",
    "  - GABA$_A$-R vs. GABA$_B$-R: 50% / 50%\n",
    "  - in brainstem, thalamus, cerebellum, spinal cord: 90% GABA$_B$-R\n",
    "  - located pre-, post- und extra-synaptically\n",
    "\n",
    "GABA$_B$-R form heterodimers\n",
    "> - B1 and B2 work together and have different functions (B1 ligand binding, B2 G-protein binding)\n",
    ">  <img  src=\"images/l2g5.png\" width=400/>\n",
    "\n",
    "GABA$_B$-receptor: effector systems \n",
    "<a id='g_i'></a>\n",
    ">- GABA$_B$-receptor binds i/o-G proteins, that have such effect:\n",
    "> <img  src=\"images/l2g7.png\" width=600/>\n",
    ">\n",
    "> Post-synaptical ($\\alpha$-subunit):\n",
    ">> Activation of GABA$_B$-R post-synaptically activ. Gi/Go $\\alpha$-SU inhibits AC $\\rightarrow$ reduction of [cAMP][2]-level $\\rightarrow$reduction of cAMP-dependent processes $\\rightarrow$ reduction of protein kinase A-level ([PKA][1]) $\\rightarrow$ no PKA – **no phosphorylation**\n",
    ">\n",
    ">Post-synaptical ($\\beta \\gamma$-subunit):\n",
    ">> activ. GABA$_B$-R post-synaptically $\\rightarrow$ activ. Gi/Go (separation of $\\alpha$-SU + $\\beta \\gamma$-SU) $\\rightarrow \\beta \\gamma$-SU binds to $K^+$-channel (GirK) $\\rightarrow$ gating: $K^+$ outflow  $\\rightarrow$ **hyperpolarisation**\n",
    ">\n",
    ">Pre-synaptic effector systems (can be done by GABA released by the same synapse (**auto receptor**), or by other neuron that inhibit synapse (**hetero receptor**) )\n",
    ">> activ. GABA$_B$-R post-synaptically $\\rightarrow$ activ. Gi/Go (separation of $\\alpha$-SU + $\\beta \\gamma$-SU) $\\rightarrow$\n",
    "$\\beta \\gamma$-SU binds to voltage gated $Ca^{2+}$ channels $\\rightarrow$ modifies voltage dependence $\\rightarrow$\n",
    "no gating – no/reduced $Ca^{2+}$-influx in pre-synapse $\\rightarrow$ **no/reduced transmitter-release**\n",
    "\n",
    "Time course \n",
    "> <img  src=\"images/l2g8.png\" width=700/>\n",
    "\n",
    "Summury\n",
    "> <img  src=\"images/l2g9.png\" width=800/>\n",
    "\n",
    "[1]: https://en.wikipedia.org/wiki/Protein_kinase_A\n",
    "[2]: https://en.wikipedia.org/wiki/Cyclic_adenosine_monophosphate"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id='l3'></a>\n",
    "### Lecture 3. Glutamate receptors"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id='l3p1'></a>\n",
    "#### Part 1. Ionotropic Glu-receptors (AMPA-Kainat-R, NMDA-R)\n",
    "\n",
    "Properties \n",
    "> - iGlu-Rs have been ‘pharmacologically’ differentiated based on their\n",
    "specific **synthetic agonists** and **antagonists**\n",
    "> - iGlu-Rs have different molecular structure (3 transmembrane domains\n",
    "+ **1 pore-element**)\n",
    "> <img  src=\"images/l3g1.png\" width=400/>\n",
    "> - They first assemble to form a\n",
    "dimer, then two dimers form a tetramer\n",
    ">  <img  src=\"images/l3g2.png\" width=500/>\n",
    "\n",
    "Ligand binding \n",
    "> - Ligand binding occurs in the\n",
    "cleft formed by lobe I + lobe II.\n",
    "The two lobes are collectively\n",
    "formed by the extracellular\n",
    "loops.\n",
    "> <img  src=\"images/l3g3.png\" width=400/>\n",
    "> - 4 Glu to one iGlu-R\n",
    "> - Glu binding and subsequent conformational change causes **tension** between dimers\n",
    "> - **affinity** of the dimer-interfaces determines the **inactivation** (desensitization):\n",
    ">  <img  src=\"images/l3g4.png\" width=700/>\n",
    "> - high affinity $\\rightarrow$ fast inactivation $\\rightarrow$ small current (iGlu-R **flop**)\n",
    "> - weak affinity $\\rightarrow$ slow inactivation $\\rightarrow$ large current (iGlu-R **flip**)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id='l3p2'></a>\n",
    "#### Part 2. NMDA \n",
    "\n",
    "We need two receptors to activate NMDA\n",
    "> - **Glycine** (or ‘D-serine’) is bound by NR1 subunits (S1-S2-half domains)\n",
    "> - **Glutamate** is bound by NR2 subunits (S1-S2-half domains)\n",
    " \n",
    "Other properties: \n",
    "> - NMDA-Rs are cation channels with **high $Ca^{2+}$-conductance**\n",
    ">   - play a major role in „synaptic plasticity“\n",
    ">   - play a role in „glutamate-toxicity“ – [$Ca^{2+}$] (when glutomate stay in extracellular space $\\rightarrow$ too many $Ca^{2+}$)\n",
    "> - NMDA-Rs are „ligand gated“ and **„voltage gated“**\n",
    ">  - gating requires [pre-depolarization][1] – removes ‘Mg2+-block’(accomplished by fast AMPA-Rs) )\n",
    "> - NMDA-Rs open and close ‘slowly’ – **late EPSP phase**\n",
    "> - NMDA-Rs have several **modulatory** binding sites  (hallucinogenic drugs(PCP), MK801, Ketamine, polyamines, pH (H$^+$))\n",
    "\n",
    "Experiment: \n",
    ">To check that NMDA-Rs close slowly, we can block it and look for difference\n",
    "> <img  src=\"images/l3g8.png\" width=500/>\n",
    "> Useful table for such experiments \n",
    "> <img  src=\"images/l3g7.png\" width=300/>\n",
    "\n",
    "NMDA-R subunits and channel properties\n",
    "> - functional channels are hetero-tetramers\n",
    "> - they consist of NR1 -+ NR2-subunits (type of NR2 is important for functions)\n",
    "> <img  src=\"images/l3g5.png\" width=500/>\n",
    "> - NR1-NR3B-heteromers form cation channels which are gated by glycine alone.\n",
    "(excitatory glycine receptor, no $Ca^{2+}$-conductance, no Mg2+-block, expressed in the\n",
    "spinal cord )\n",
    "\n",
    " \n",
    "\n",
    "Summary \n",
    "> <img  src=\"images/l3g6.png\" width=700/>\n",
    "[1]:..\\neurophisiology\\neurophysiology.ipynb#l5p3"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id='l3p3'></a>\n",
    "### Part 3. Metabotropic Glu-R\n",
    "\n",
    "#### mGlu-Rs are the most important neuromodulators in the brain \n",
    "\n",
    "#### mGlu-Rs are most abundant in the brain\n",
    " <img  src=\"images/l3g9.png\" width=700/>\n",
    "\n",
    "Classification(**3 groups** confirmed):\n",
    "  - sequence homology(Group I: R1, R5; Group II: R2,R3, Group III: R4, R6, R7, R8)\n",
    "  - pharmacologically\n",
    "  - by G-prot. / sec.mess. couplings(Group I: $G_q$; Group II:$G_i$ Group III: $G_i$ ([the same][1] as in GABA$_B$))\n",
    "\n",
    "Modulation\n",
    ">  <img  src=\"images/l3g10.png\" width=700/>\n",
    "\n",
    "Group I and $G_q$-protein\n",
    "> - activation of [PLC][2] $\\rightarrow$ [IP3][3] $\\rightarrow$ $Ca^{2+}$ -release from intracellular stores\n",
    ">   - mGlu-R1: single $Ca^{2+}$-pulses $\\rightarrow$ activation of **cation-channels**\n",
    "or activation of **$Ca^{2+}$-depend proteins**\n",
    ">   - mGlu-R5: $Ca^{2+}$-oscillations (2/min) $\\rightarrow$ activ. transcription factor $\\rightarrow$ **gene expression**\n",
    "> - activation of PLC $\\rightarrow$ [DAG][4] $\\rightarrow$ activation of PKC $\\rightarrow$ phosphorylation of target proteins\n",
    "$\\rightarrow$ activ. [MAP kinase][5] $\\rightarrow$ transcription factor $\\rightarrow$ **gene expression**\n",
    "\n",
    "mGlu can induce IPSP \n",
    "> <img  src=\"images/l3g11.png\" width=700/>\n",
    "[1]:#g_i\n",
    "[2]:https://en.wikipedia.org/wiki/Phospholipase_C\n",
    "[3]:#ip_3\n",
    "[4]:https://en.wikipedia.org/wiki/Diglyceride\n",
    "[5]:https://en.wikipedia.org/wiki/Mitogen-activated_protein_kinase"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id='l4' ></a>\n",
    "### Lecture 4. Neurotransmitter Transporters"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id='l4p1' ></a>\n",
    "#### Part 1. Introduction\n",
    "\n",
    "Cell membrane is a barrier for many molecules \n",
    "> - Barrier allows for intra- vs. extracellular\n",
    "**concentration differences** $\\rightarrow$ resting potential\n",
    "- Barrier allows for **precisely controlling** what\n",
    "goes in-and-out of a cell.\n",
    "- Up to **30% of all genes code** for transport\n",
    "proteins.\n",
    "- Neurons devote the **majority of their\n",
    "metabolic energy** consumption to\n",
    "membrane transport mechanisms ($Na^+-K^+$ pumps burn up to 2/3 of the energy of neurons)\n",
    "> <img  src=\"images/l4g1.png\" width=500/>\n",
    "\n",
    "Passive transport vs Active transport \n",
    ">  <img  src=\"images/l4g2.png\" width=700/>\n",
    "\n",
    "Active transport \n",
    "> the $Na^+-K^+$ pump actively pumps **$Na^+$-ions out** of the cell and $K^+$-ions into\n",
    "the cell – **against their concentration gradients**.\n",
    ">  <img  src=\"images/l4g3.png\" width=500/>\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id='l4p2' ></a>\n",
    "#### Part 2. Neurotransmitter (re)-uptake\n",
    "\n",
    "- Every part of synapse has NT transporter. Vesicles also have( transport against their gradient).\n",
    "<img  src=\"images/l4g5.png\" width=500/>\n",
    "\n",
    " - Transporters are **slow** (takes several 10 ms for 1 transport cycle)\n",
    " - BUT to compensate this:\n",
    "   - NT transporters are: **expressed abundantly** / in high density\n",
    "   - transporters bind NT with **high affinity**\n",
    " - The number of „high affinity binding sites“ (= NT-receptors + NT-transporters)\n",
    "is such that NT-molecules from 1 release event is **completely bound**\n",
    " - The NT-transporters are ‚done‘ with a cycle and **ready again** when\n",
    "NT-molecules are **unbound from the NT-receptors** (so all molecules turn back in intracellular space of post-, pre-synaptic site or astrocyte )\n",
    " - So this makes NT short in time. So EPSP is near in time with AP and we have communication\n",
    "\n",
    "SLC(**s**o**l**ute **c**arrier)\n",
    "<img  src=\"images/l4g6.png\" width=700/>\n",
    "\n",
    "\n",
    "Glutamate-transporter\n",
    ">“Cooperative” binding:\n",
    ">   - $3Na^+$, $H^+$, $Glu$ **in** $\\rightarrow$ change in conformation $\\rightarrow$ $K^+$ **out** $\\rightarrow$ change in conformation $\\rightarrow$ ... \n",
    "> <img  src=\"images/l4g7.png\" width=500/>"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id='l4p3' ></a>\n",
    "#### Part 3. NT release by “reversed uptake”\n",
    "- Transporter can always work in **different direction** if the **concentrations** changed dramatically (for example not enough energy for **$Na^+-K^+$ pump**) \n",
    "\n",
    "Glutamate (pathological conditions)\n",
    "> <img  src=\"images/l4g8.png\" width=700/>\n",
    "\n",
    "GABA (negative feedback)\n",
    "> <img  src=\"images/l4g9.png\" width=700/>"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id='l4p4' ></a>\n",
    "#### Part 4. Clinical relevance \n",
    "- Dopamine-Transporter & Addiction \n",
    "  - Cocaine block Dopamine(DA) transporter $\\rightarrow$ re-uptake of DA is blocked $\\rightarrow$ increased concentration of DA $\\rightarrow$ \"reward\" (in NA) $\\rightarrow$ the reinforcing effects finally leading to **cocaine addiction**\n",
    "- Serotonin-Transporter & Depression\n",
    "  - several psychiatric and affective / emotional disorders are caused by a malfunctioning **serotonergic** system / SERTs (depression, anxiety disorders, obsessive-compulsive disorders, …)\n",
    "  - treatment with **drugs that block the uptake of 5-HT** $\\rightarrow$ increased concentration of 5-HT in the synaptic cleft (for example, Prozac)\n",
    "- GABA-Transporter & Epilepsy\n",
    " - GABA-Transporters (GATs) are targets of **anticonvulsive** substances \n",
    " - epileptic **seizures** can be suppressed by **increasing cortical inhibition**\n",
    " - application of drugs that **prevent the uptake of\n",
    "GABA** from the synaptic cleft $\\rightarrow$ **increased concentration of GABA** in the synapse $\\rightarrow$ increased **inhibition** $\\rightarrow$ strong **anti-convulsive effects**(for example, Tiagabine )"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Signal Transduction - General\n",
    "\n",
    "Ionotropic vs. metabotropic receptors:\n",
    "- General molecular composition of these receptor types.\n",
    "- Difference between cation vs. anion channels (ACh-/GABA$_A$-rec.).\n",
    "- General features of ionotropic vs. metabotropic receptors (time\n",
    "course, effects, duration of effects, amplification, cross-talk).\n",
    "- Metabotropic receptor: signal transduction from extracellular to\n",
    "intracellular – sec. mess. cascades – ‘long’ vs. ‘short’ cascades.\n",
    "\n",
    "$Ca^{2+}$ functions in excitable cells\n",
    "- Name a few functions of $Ca^{2+}$ in neurons …\n",
    "- Name the major structures/mechanisms by which $Ca^{2+}$  enters the\n",
    "cytoplasm.\n",
    "- Mechanisms by which $Ca^{2+}$ action is ceased/buffered and\n",
    "mechanisms of $Ca^{2+}$  removal.\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### GABA receptors\n",
    "GABA$_A$-receptors\n",
    "- Subunits / subunit composition – function …\n",
    "- Distinctive features of GABA$_A$-receptors – pharmacology.\n",
    "- Physiological effect of GABA$_A$ activation.\n",
    "- Potentiation of GABA$_A$-currents.\n",
    "\n",
    "GABA$_B$-receptors\n",
    "- Molecular composition / VFTM / hetero-dimer.\n",
    "- Occurrence in the CNS.\n",
    "- Second messenger coupling:\n",
    "    - Pre-synaptic localization – effect (in detail).\n",
    "    - Post-synaptic localization – effect (in detail)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Glutamate Receptors\n",
    "Ionotropic glutamate-receptors\n",
    "- Molecular composition – gating / compare.\n",
    "- Characterize the two classes of iGlu-receptors.\n",
    "- Major function of AMPA-receptors.\n",
    "- Distinctive features of NMDA-receptors (in detail).\n",
    " - Gating mechanisms / major function.\n",
    "\n",
    "Metabotropic glutamate-receptors\n",
    "- 8 types – 3 groups / how are the “Groups” characterized?\n",
    "- Second messenger coupling Group II and III.\n",
    "- Second messenger coupling Group I (in detail).\n",
    "- Occurrence of mGlu-Rs in the CNS."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Neurotransmitter Transporters\n",
    "- Why do neurons need ‘trans-membrane transport mechanisms’ ?\n",
    "- Describe the working principles of ‘pumps’ vs. ‘transporters’.\n",
    "- Where in the neuropil are NT-transporters located?\n",
    "- Why are NT-transporters crucial for chemical neurotransmission?\n",
    "- Example of NT-transporters acting as ‘drug’ targets."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Questions\n",
    "\n",
    "Lecture 1. What is the function of rapsyn?"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "collapsed": true
   },
   "source": [
    "### Lecture 8. Glia "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<!--Mircoglia - from mesemchymal cells, travel from blood and became mircoglia \n",
    "\n",
    "Astrocytes - \n",
    "\n",
    "apoltosis (delete neurons that are not needed in the development)\n",
    "\n",
    "supply energy \n",
    "\n",
    "modulation of synaptic transmission \n",
    "\n",
    "homeostasis - take care of balance of differt ions, whater, pH\n",
    "\n",
    "Depending of contact site :\n",
    " - neighboring astrocytes \n",
    " - pia\n",
    " - blood \n",
    " - synapses \n",
    " \n",
    "They express different things: \n",
    " - -->"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python [Root]",
   "language": "python",
   "name": "Python [Root]"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 0
}
